Clave Capital

Clave Capital is a prominent venture capital firm based in Pamplona, Spain, with a strong focus on the healthcare sector. Notable for their recent €50 million Clave Innohealth fund, they target high-growth potential startups across Europe, specifically in medtech, digital health, health-nutrition, and biotech sectors. Clave Capital’s portfolio includes promising startups like Innitius, which focuses on improving diagnostics for women’s health. Clave Capital primarily invests in early-stage to Series A funding rounds, with initial contributions ranging from €500k to €1 million, and potential follow-on investments up to €3 million per project. Their geographic focus extends throughout Spain and Europe. The firm’s investment strategy emphasizes not only financial backing but also active involvement in the growth and development of their portfolio companies. They maintain close relationships with research centers and hospitals, providing valuable expertise and connections to foster innovation. Clave Capital's experienced team, led by Chairman and CEO José Javier Armendariz and Director of Funds Santiago Lozano, has a track record of over 20 years and 90 investments, which positions them as a significant player in the European healthcare investment landscape. For startups looking to engage with Clave Capital, it’s advisable to highlight innovative potential and market leadership capabilities in the healthcare domain. Their preference for hands-on involvement means that demonstrating a collaborative approach could be beneficial.